BACKGROUND: Psychometric information on the World Health Organization Disability Assessment Schedule II (WHO-DAS II) in depressive primary care (PC) patients is scarce and has been obtained with the 36-item version of the instrument. The main objective of this study was to analyse the dimensionality, internal consistency and construct validity of the 12-item WHO-DAS II in a large sample of Spanish PC patients with a first diagnosed major depressive episode. METHOD: Data were collected between December 2006 and July 2007. A total of 3615 adult (18 years or older) PC patients from 17 regions of Spain with a first diagnosed major depressive episode participated in the study. The 12-item WHO-DAS II and a battery of instruments assessing sociodemographic characteristics, depression severity (PHQ-9), quality of life (EQ-5D) and chronic health conditions were administered by the family physician during the consultation. RESULTS: The principal component analysis and the subsequent confirmatory factor analysis indicated that the 12-item WHO-DAS II is one-dimensional. The instrument showed adequate internal consistency (alpha=0.89) and construct validity because it was significantly associated with quality of life and depression severity (convergent validity) and was able to discriminate between patients on sick leave and those that were working (discriminative validity). LIMITATIONS: The test-retest reliability and sensitivity to change of the instrument was not examined due to the cross-sectional design of the study. CONCLUSIONS: The 12-item WHO-DAS II is a reliable, valid and useful tool for assessing overall disability in PC patients with depression. 2009 Elsevier B.V. All rights reserved.
BACKGROUND: Psychometric information on the World Health Organization Disability Assessment Schedule II (WHO-DAS II) in depressive primary care (PC) patients is scarce and has been obtained with the 36-item version of the instrument. The main objective of this study was to analyse the dimensionality, internal consistency and construct validity of the 12-item WHO-DAS II in a large sample of Spanish PC patients with a first diagnosed major depressive episode. METHOD: Data were collected between December 2006 and July 2007. A total of 3615 adult (18 years or older) PC patients from 17 regions of Spain with a first diagnosed major depressive episode participated in the study. The 12-item WHO-DAS II and a battery of instruments assessing sociodemographic characteristics, depression severity (PHQ-9), quality of life (EQ-5D) and chronic health conditions were administered by the family physician during the consultation. RESULTS: The principal component analysis and the subsequent confirmatory factor analysis indicated that the 12-item WHO-DAS II is one-dimensional. The instrument showed adequate internal consistency (alpha=0.89) and construct validity because it was significantly associated with quality of life and depression severity (convergent validity) and was able to discriminate between patients on sick leave and those that were working (discriminative validity). LIMITATIONS: The test-retest reliability and sensitivity to change of the instrument was not examined due to the cross-sectional design of the study. CONCLUSIONS: The 12-item WHO-DAS II is a reliable, valid and useful tool for assessing overall disability in PC patients with depression. 2009 Elsevier B.V. All rights reserved.
Authors: Amy M Kilbourne; David E Goodrich; Kristina M Nord; Celeste Van Poppelen; Julia Kyle; Mark S Bauer; Jeanette A Waxmonsky; Zongshan Lai; Hyungjin M Kim; Daniel Eisenberg; Marshall R Thomas Journal: Adm Policy Ment Health Date: 2015-09
Authors: Melissa A MacLeod; Paul F Tremblay; Kathryn Graham; Sharon Bernards; Jürgen Rehm; Samantha Wells Journal: Int J Methods Psychiatr Res Date: 2016-09-15 Impact factor: 4.035
Authors: Juan V Luciano; José L Ayuso-Mateos; Ana Fernandez; Jaume Aguado; Antoni Serrano-Blanco; Miquel Roca; Josep M Haro Journal: Qual Life Res Date: 2009-12-18 Impact factor: 4.147
Authors: Juan V Luciano; José L Ayuso-Mateos; Jaume Aguado; Ana Fernandez; Antoni Serrano-Blanco; Miquel Roca; Josep M Haro Journal: BMC Med Res Methodol Date: 2010-05-20 Impact factor: 4.615
Authors: Paul Kowal; Kathleen Kahn; Nawi Ng; Nirmala Naidoo; Salim Abdullah; Ayaga Bawah; Fred Binka; Nguyen T K Chuc; Cornelius Debpuur; Alex Ezeh; F Xavier Gómez-Olivé; Mohammad Hakimi; Siddhivinayak Hirve; Abraham Hodgson; Sanjay Juvekar; Catherine Kyobutungi; Jane Menken; Hoang Van Minh; Mathew A Mwanyangala; Abdur Razzaque; Osman Sankoh; P Kim Streatfield; Stig Wall; Siswanto Wilopo; Peter Byass; Somnath Chatterji; Stephen M Tollman Journal: Glob Health Action Date: 2010-09-27 Impact factor: 2.640
Authors: J Christopher Fowler; Michelle A Patriquin; Alok Madan; Jon G Allen; B Christopher Frueh; John M Oldham Journal: Int J Methods Psychiatr Res Date: 2016-09-27 Impact factor: 4.035
Authors: Kirsten Sjonnesen; Andrew G M Bulloch; Jeanne Williams; Dina Lavorato; Scott B Patten Journal: Can J Psychiatry Date: 2016-02-16 Impact factor: 4.356
Authors: Enrique Alvarez; Jose L Carrasco; José M Olivares; Vanessa López-Gómez; Inma Vilardaga; María Perez Journal: Clin Pract Epidemiol Ment Health Date: 2012-11-16